| Document and Entity Information - shares | 9 Months Ended | |
| Sep. 30, 2020 | Nov. 05, 2020 | |
| Document And Entity Information | ||
| Entity Registrant Name | C & C TOURS INC | |
| Entity Central Index Key | 0001430319 | |
| Document Type | 10-Q | |
| Document Period End Date | Sep. 30, 2020 | |
| Entity Incorporation, State or Country Code | WY | |
| Amendment Flag | false | |
| Current Fiscal Year End Date | --12-31 | |
| Entity File Number | 000-54847 | |
| Is Entity's Reporting Status Current? | Yes | |
| Entity Interactive Data Current | Yes | |
| Is Entity Emerging Growth Company? | true | |
| Elected Not To Use the Extended Transition Period | false | |
| Entity Filer Category | Non-accelerated Filer | |
| Entity Small Business | true | |
| Entity Common Stock, Shares Outstanding | 2,937,000 | |
| Document Fiscal Period Focus | Q3 | |
| Document Fiscal Year Focus | 2020 | |
| Entity Shell Company | true |
| Condensed Balance Sheets (Unaudited) - USD ($) | Sep. 30, 2020 | Dec. 31, 2019 |
| CURRENT ASSETS | ||
| Cash | $ 4,274 | $ 374 |
| Total current assets | 4,274 | 374 |
| TOTAL ASSETS | 4,274 | 374 |
| CURRENT LIABILITIES | ||
| Accounts payable | 12,000 | 10,200 |
| Notes payable - current | 177,940 | 164,940 |
| Accrued interest | 67,661 | 57,586 |
| Total current liabilities | 257,601 | 232,726 |
| TOTAL LIABILITIES | 257,601 | 232,726 |
| STOCKHOLDERS' DEFICIT | ||
| Common stock, 20,000,000 shares authorized at $.001 par value, 2,937,000 shares issued and outstanding | 2,937 | 2,937 |
| Additional paid-in capital | 34,970 | 34,970 |
| Accumulated deficit | (291,234) | (270,259) |
| Stotal stockholders' deficit | (253,327) | (232,352) |
| TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT | $ 4,274 | $ 374 |
| Condensed Balance Sheets (Parenthetical) - $ / shares | Sep. 30, 2020 | Dec. 31, 2019 |
| Statement of Financial Position [Abstract] | ||
| Common stock, par value | $ 0.001 | $ 0.001 |
| Common stock, authorized | 20,000,000 | 20,000,000 |
| Common stock, issued | 2,937,000 | 2,937,000 |
| Common stock, outstanding | 2,937,000 | 2,937,000 |
| Condensed Statements of Operations (Unaudited) - USD ($) | 3 Months Ended | 9 Months Ended | ||
| Sep. 30, 2020 | Sep. 30, 2019 | Sep. 30, 2020 | Sep. 30, 2019 | |
| Income Statement [Abstract] | ||||
| Revenues | ||||
| Operating expenses | ||||
| General and administrative | 2,700 | 2,900 | 10,900 | 11,300 |
| Total operating expenses | 2,700 | 2,900 | 10,900 | 11,300 |
| Net operating loss before other expense | (2,700) | (2,900) | (10,900) | (11,300) |
| Other income (expense) | ||||
| Interest expense | (3,473) | (3,164) | (10,075) | (9,325) |
| Total other income (expense) | (3,473) | (3,164) | (10,075) | (9,325) |
| Loss from operations before income taxes | (6,173) | (6,064) | (20,975) | (20,625) |
| Income taxes | ||||
| Net loss | $ (6,173) | $ (6,064) | $ (20,975) | $ (20,625) |
| Basic and diluted net loss per share | $ 0 | $ 0 | $ (0.01) | $ (0.01) |
| Weighted average shares outstanding | 2,937,000 | 2,937,000 | 2,937,000 | 2,937,000 |
| Condensed Statement of Stockholders’ Deficit (Unaudited) - USD ($) | Common Stock | Additional Paid-In Capital | Accumulated Deficit | Total |
| Beginning balance, shares at Dec. 31, 2018 | 2,937,000 | |||
| Beginning balance, amount at Dec. 31, 2018 | $ 2,937 | $ 34,970 | $ (243,570) | $ (205,663) |
| Net loss | (8,545) | (8,545) | ||
| Ending balance, shares at Mar. 31, 2019 | 2,937,000 | |||
| Ending balance, amount at Mar. 31, 2019 | $ 2,937 | 34,970 | (252,115) | (214,208) |
| Beginning balance, shares at Dec. 31, 2018 | 2,937,000 | |||
| Beginning balance, amount at Dec. 31, 2018 | $ 2,937 | 34,970 | (243,570) | (205,663) |
| Net loss | (20,625) | |||
| Ending balance, shares at Sep. 30, 2019 | 2,937,000 | |||
| Ending balance, amount at Sep. 30, 2019 | $ 2,937 | 34,970 | (264,195) | (226,288) |
| Beginning balance, shares at Mar. 31, 2019 | 2,937,000 | |||
| Beginning balance, amount at Mar. 31, 2019 | $ 2,937 | 34,970 | (252,115) | (214,208) |
| Net loss | (6,016) | (6,016) | ||
| Ending balance, shares at Jun. 30, 2019 | 2,937,000 | |||
| Ending balance, amount at Jun. 30, 2019 | $ 2,937 | 34,970 | (258,131) | (220,224) |
| Net loss | (6,064) | (6,064) | ||
| Ending balance, shares at Sep. 30, 2019 | 2,937,000 | |||
| Ending balance, amount at Sep. 30, 2019 | $ 2,937 | 34,970 | (264,195) | (226,288) |
| Beginning balance, shares at Dec. 31, 2019 | 2,937,000 | |||
| Beginning balance, amount at Dec. 31, 2019 | $ 2,937 | 34,970 | (270,259) | (232,352) |
| Net loss | (8,796) | (8,796) | ||
| Ending balance, shares at Mar. 31, 2020 | 2,937,000 | |||
| Ending balance, amount at Mar. 31, 2020 | $ 2,937 | 34,970 | (279,055) | (241,148) |
| Beginning balance, shares at Dec. 31, 2019 | 2,937,000 | |||
| Beginning balance, amount at Dec. 31, 2019 | $ 2,937 | 34,970 | (270,259) | (232,352) |
| Net loss | (20,975) | |||
| Ending balance, shares at Sep. 30, 2020 | 2,937,000 | |||
| Ending balance, amount at Sep. 30, 2020 | $ 2,937 | 34,970 | (291,234) | (253,327) |
| Beginning balance, shares at Mar. 31, 2020 | 2,937,000 | |||
| Beginning balance, amount at Mar. 31, 2020 | $ 2,937 | 34,970 | (279,055) | (241,148) |
| Net loss | (6,006) | (6,006) | ||
| Ending balance, shares at Jun. 30, 2020 | 2,937,000 | |||
| Ending balance, amount at Jun. 30, 2020 | $ 2,937 | 34,970 | (285,061) | (247,154) |
| Net loss | (6,173) | (6,173) | ||
| Ending balance, shares at Sep. 30, 2020 | 2,937,000 | |||
| Ending balance, amount at Sep. 30, 2020 | $ 2,937 | $ 34,970 | $ (291,234) | $ (253,327) |
| Condensed Statements of Cash Flows (Unaudited) - USD ($) | 9 Months Ended | |
| Sep. 30, 2020 | Sep. 30, 2019 | |
| Cash Flows from Operating Activities | ||
| Net Loss | $ (20,975) | $ (20,625) |
| Changes in operating assets and liabilities: | ||
| Accounts payable | 1,800 | 6,000 |
| Accrued interest | 10,075 | 9,324 |
| Net cash used by operating activities | (9,100) | (5,301) |
| Cash Flows from Investing Activities | ||
| Net cash provided (used) by investing activities | ||
| Cash Flows from Financing Activities | ||
| Proceeds from notes payable | 13,000 | 5,400 |
| Net cash provided by financing activities | 13,000 | 5,400 |
| Net Increase (Decrease) in Cash | 3,900 | 99 |
| Cash at Beginning of Period | 374 | 275 |
| Cash at End of Period | 4,274 | 374 |
| Supplemental Cash Flow Information: | ||
| Cash paid for interest | ||
| Cash paid for income taxes | ||
| CONDENSED FINANCIAL STATEMENTS | 9 Months Ended |
| Sep. 30, 2020 | |
| Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
| CONDENSED FINANCIAL STATEMENTS | NOTE 1 – CONDENSED FINANCIAL STATEMENTS The accompanying financial statements have been prepared by the Company without audit. In the opinion of management, all adjustments (which include only normal recurring adjustments) necessary to present fairly the financial position, results of operations and cash flows as of and for the period ended September 30, 2020 and for all periods presented have been made. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted. It is suggested that these condensed financial statements be read in conjunction with the financial statements and notes thereto included in the Company’s December 31, 2019 audited financial statements as reported in its Form 10-K. The results of operations for the nine month period ended September 30, 2020 are not necessarily indicative of the operating results for the full year ended December 31, 2020. |
| GOING CONCERN | 9 Months Ended |
| Sep. 30, 2020 | |
| Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
| GOING CONCERN | NOTE 2 – GOING CONCERN The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. The Company has limited assets, has incurred losses since inception, has negative cash flows from operations, and has no revenue-generating activities. Its activities have been limited for the past several years and it is dependent upon financing to continue operations. These factors raise substantial doubt about the ability of the Company to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. It is management’s plan to acquire or merge with other operating companies. The COVID-19 pandemic could have an impact on our ability to obtain financing to fund our operations. The Company is unable to predict the ultimate impact at this time. |
| NOTES PAYABLE | 9 Months Ended |
| Sep. 30, 2020 | |
| Debt Disclosure [Abstract] | |
| NOTES PAYABLE | NOTE 3 – NOTES PAYABLE During the nine months ended September 30, 2020, the Company was loaned $13,000. As of September 30, 2020 and December 31, 2019, notes payable were $177,940 and $164,940 respectively. These loans are due on demand and bear interest at the rate of 8%. Interest expense on the loans for the nine months ended September 30, 2020 and 2019 were $10,075 and $9,325 respectively resulting in accrued interest of $67,661 and $57,586 at September 30, 2020 and December 31, 2019, respectively. |
| SUBSEQUENT EVENTS | 9 Months Ended |
| Sep. 30, 2020 | |
| Subsequent Events [Abstract] | |
| SUBSEQUENT EVENTS | NOTE 4 – SUBSEQUENT EVENTS The Company’s management reviewed all material events through the date of this filing and has determined that there are no material subsequent events to report. |
| NOTES PAYABLE (Details Narrative) - USD ($) | 9 Months Ended | ||
| Sep. 30, 2020 | Sep. 30, 2019 | Dec. 31, 2019 | |
| Debt Disclosure [Abstract] | |||
| Loans to the Company | $ 13,000 | ||
| Notes payable - current | $ 177,940 | $ 164,940 | |
| Interest rate | 8.00% | 8.00% | |
| Interest expense on loans | $ 10,075 | $ 9,325 | |
| Accrued interest on notes payable | $ 67,661 | $ 57,586 | |
